Brinker Capital Investments’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,390	Closed	-$257K	–	1898
2024 Q4	$257K	Sell	1,390 -1,847	-57%	-$356K	﹤0.01%	1629
2024 Q3	$638K	Sell	3,237 -67	-2%	-$13.9K	0.01%	1243
2024 Q2	$683K	Sell	3,304 -74	-2%	-$16.8K	0.01%	1163
2024 Q1	$915K	Sell	3,378 -38	-1%	-$9.07K	0.01%	1026
2023 Q4	$775K	Sell	3,416 -602	-15%	-$118K	0.01%	1049
2023 Q3	$787K	Sell	4,018 -560	-12%	-$115K	0.01%	1033
2023 Q2	$963K	Sell	4,578 -107	-2%	-$21.3K	0.01%	970
2023 Q1	$946K	Sell	4,685 -474	-9%	-$107K	0.01%	899
2022 Q4	$1.12M	Sell	5,159 -269	-5%	-$58.7K	0.02%	695
2022 Q3	$1.07M	Buy	5,428 +149	+3%	+$32.2K	0.02%	682
2022 Q2	$1.13M	Sell	5,279 -632	-11%	-$154K	0.02%	689
2022 Q1	$1.68M	Sell	5,911 -261	-4%	-$80.5K	0.03%	597
2021 Q4	$2.33M	Buy	6,172 +1,041	+20%	+$404K	0.03%	514
2021 Q3	$1.9M	Hold	5,131	–	–	0.03%	560
2021 Q2	$1.9M	Sell	5,131 -525	-9%	-$175K	0.03%	613
2021 Q1	$1.64M	Sell	5,656 -1,828	-24%	-$508K	0.02%	567
2020 Q4	$1.87M	Buy	7,484 +3,379	+82%	+$805K	0.03%	567
2020 Q3	$930K	Buy	+4,105	New	+$852K	0.02%	708